Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
NCCN Conference
Cancer and Corporate America: Business as Usual?
By
Audrey Andrews
NCCN Conference
June 2012, Vol 3, No 4
Hollywood, FL—Is corporate America doing enough to promote optimal cancer care? The provision of insurance coverage alone is no longer sufficient for America’s workers.
Read Article
Updated NCCN Practice Guidelines in Oncology Include 3 New Panels
By
Audrey Andrews
NCCN Conference
May 2012, Vol 3, No 3
The National Comprehensive Cancer Network (NCCN) introduced 3 new panels to its Clinical Practice Guidelines in Oncology™ at its 2012 annual conference.
Read Article
Cancer Diagnosis Increases Suicide Risk or CV Death in the First Few Weeks
NCCN Conference
May 2012, Vol 3, No 3
Patients receiving a diagnosis of cancer are at increased risk for suicide and other adverse health effects that are triggered by the trauma associated with such a diagnosis, according to results of a recent study (Fang F, et al.
N Engl J Med
. 2012;366:1310-1318).
Read Article
NCCN Clinical Practice Guidelines Update
By
Audrey Andrews
NCCN Conference
May 2012, Vol 3, No 3
The 2012 updates to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology™ have elevated several drugs to category 1 recommendation and have changed the algorithm for work-up in some tumors. A synopsis of the key updates presented at the 2012 annual conference is reported here.
Read Article
Optimal Care for Patients with Cancer: Who Decides?
By
Audrey Andrews
NCCN Conference
May 2012, Vol 3, No 3
Hollywood, FL—Cancer care today is influenced by an ever-broadening array of players, and what was once an intimate relationship between patient and physician now involves multiple decision makers. At the 2012 National Comprehensive Cancer Network (NCCN) meeting, a panel of various stakeholder groups addressed the questions of what and who defines “optimal care” for today’s patient.
Read Article
“Pediatric-Inspired” Regimens Improve Outcomes in Adults with ALL
By
Phoebe Starr
NCCN Conference
December 2011, Vol 2, No 7
Adults with acute lymphoblastic leukemia (ALL) have a poor prognosis compared with children, but recent studies suggest that using “pediatric-inspired” regimens can improve outcomes for patients with Philadelphia chromosome(Ph)- negative ALL.
Read Article
NCCN 2011 Clinical Guidelines Updates
By
Robert W. Carlson, MD
Clinical Guidelines
,
NCCN Conference
,
Policies & Guidelines
April 2011, Vol 2, No 2
Chairpersons of the various National Comprehensive Cancer Network (NCCN) tumor panels presented clinical practice updates at the recent 16th Annual Conference of the NCCN. Key updates, and relevant discussions, are highlighted.
Read Article
NCCN Expert Panel Considers Value, Utilization of Molecular Testing in Clinical Practice
By
Lee N. Newcomer, MD, MHA
NCCN Conference
April 2011, Vol 2, No 2
Read Article
The NCCN Task Force on Specialty Pharmacy Issues Preliminary Report
NCCN Conference
May 2010, Vol 1, No 1
Hollywood, FL—As specialty pharmacy (SP) expands rapidly into oncology, there is a need to better define its role. This was the aim of the National Comprehensive Cancer Network (NCCN) Task Force on Specialty Pharmacy, whose chair presented the group’s preliminary report at the 15th Annual NCCN Conference.
Read Article
NCCN Roundtable: Clinical and Economic Issues Impacting Cancer Care Delivery
NCCN Conference
May 2010, Vol 1, No 1
At a roundtable held during the NCCN’s 15th Annual Conference, moderator Clifford Goodman, PhD, Senior Vice President at The Lewin Group, predicted, “The appropriate use of evidence-based guidelines is on a collision course with the financial nonsustainability of the healthcare system.”
Read Article
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma